Related Experiment Video
Updated: Dec 27, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Abstract:
Angiosarcoma Project researchers have uncovered some details about the molecular underpinnings of angiosarcoma, pointing to potential therapeutic options. Their work also suggests that a research model based on direct patient participation can overcome common barriers to studying rare diseases.
Insights
Researchers uncovered molecular details of angiosarcoma, revealing potential therapeutic targets. Patient participation in research models can overcome challenges in studying rare diseases like angiosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Rare Diseases Research
Background:
- Angiosarcoma is a rare and aggressive cancer with limited treatment options.
- Understanding the molecular basis of angiosarcoma is crucial for developing targeted therapies.
Discussion:
- The Angiosarcoma Project has shed light on the molecular mechanisms driving angiosarcoma.
- This research identifies potential therapeutic avenues for angiosarcoma patients.
Key Insights:
- Molecular underpinnings of angiosarcoma have been elucidated.
- Direct patient participation in research models proves effective for rare disease studies.
Outlook:
- Findings may lead to novel therapeutic strategies for angiosarcoma.
- The patient-centric research model can accelerate rare cancer research.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Tumor Immunotherapy

